Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 352

Advances in Cancer Prevention received 352 citations as per Google Scholar report

Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Euro Pub
  • ICMJE
Share This Page

Qiang Nai

Qiang Nai

Qiang Nai
Professor
Department of Anatomy and Neurobiology
University of Tennessee
USA
Tel: 901 337 8051

University of Tennessee

Biography

Dr. Qiang Nai received his medical degree from the Shandong Medical University, China, and Master of Public Health from Beijing Medical University, China. He obtained PhD degree in Neuroscience from the Medical College of Ohio in 2002. Dr. Nai did the post-doctoral training in neuroscience at the University of California, San Diego, and the Centre for Addiction and Mental Health, Toronto, Canada. He joined the faculty at the Department of Anatomy and Neurobiology, University of Tennessee, Health Science Center in 2007. His academic activities resulted in a number of articles published in high profile journals. Dr. Nai has interest in becoming a physician-scientist, and he joined the residency program in internal medicine at the Raritan Bay Medical Center in 2013. He developed intense interest in Hematology and Oncology and has been actively involved in multiple projects in the clinical research and cancer patient management.

Research Interest

Clinical model predicting pancreatic cancer
Cancer Screening
biomarkers for pancreatic cancer
 

Certificate

Certificate

Publications

Elements of Risk and Risk Assessment in Cancer Risk Reduction

The Onco-Genomic Alterations Existing in Cancer Genotypes

Qiang Nai
: Adv Cancer Prev

Genesis Inhibitors with External Adrenaline Updation

Qiang Nai
: Adv Cancer Prev

Extracellular Vesicles for Cancer Diagnosis and Therapy

Qiang Nai
: Adv Cancer Prev

Inhibitors: Class of Drugs Used in the Off Label Treatment

Qiang Nai
: Adv Cancer Prev

At a Glance of Different Stages and Causes of Skin Cancer

Qiang Nai
: Adv Cancer Prev

Chemoprevention Using Pharmaceutical Agents in Cancer Treatment

Qiang Nai
: Adv Cancer Prev 2022, 6:131
Qiang Nai
: Adv Cancer Prev 2022, 6:126
Relevant Topics
Top